The lysosomal cysteine proteinases cathepsins B and L are known to play an important role in the invasive growth of tumor cells, but their association with angiogenesis has been less well studied. The aim of this study was to determine the possible role of endothelial cell-associated cathepsins B and L in induced capillary growth in the aorta ring model of angiogenesis. Specific inhibitors of cysteine proteinases did not inhibit capillary growth in aorta ring culture and only slightly inhibited the degradation of surrounding collagen. In contrast, strong inhibition of both processes by the matrix metalloproteinase inhibitor BB-94 was observed, indicating the importance of endogenous MMP production in angiogenesis. In support of this finding, we demonstrated a significant increase in endogenous endothelial mRNA of MMP2, but not of cathepsins B and L, in proliferating primary human dermal microvascular endothelial cells (HMVEC-d) in culture. However, MMP2 mRNA expression was increased only when the cells were embedded in collagen but not when they were grown on plastic, regardless of the addition of the growth factors VEGF or bFGF. Moreover, on plastic the impairment of MMP2 induction by growth factors was observed. The differential effect of growth factors implies the crosstalk with integrin signaling as a consequence of binding to the different matrix. This study suggests that endothelial cell-associated cathepsins B and L are not involved in the invasive growth of capillaries from existing blood vessels and that the presence of collagen is necessary for MMP2 expression in endothelial cells. (Int J Biol Markers 2004; 19: 120-9)
INTRODUCTION
Angiogenesis is a normal physiological process that occurs during development, in wound healing, during ovulation and in the formation of collaterals during ischemia (1) . Several pathological states also involve the formation of undesirable new vessels, like arthritis, diabetic retinopathy, chronic inflammation and tumor growth (1, 2) . It has been shown recently that tumor capillaries may form by sprouting or intussusception from pre-existing vessels, by incorporation of progenitor cells and by lymphangiogenesis (2) . Sprouting of capillaries from a pre-existing vessel depends on proteolytic degradation of the extracellular matrix. It has been demonstrated that matrix metalloproteinases (MMPs) and the plasminogen-plasminogen activator system (Plg-PA) play a major role in this process (3) (4) (5) .
However, not much is known about the possible involvement of lysosomal cathepsins in the process. The vast body of literature shows that cathepsins (Cat) B and L play a major role in lysosomal digestion and specific processing of proteins in other cellular compartments, thereby participating in immunological processes, apop-tosis, inflammation and in invasion of various types of tumor (6, 7) . CatB and CatL are also involved in matrix remodeling in non-cancerous tissues (8) (9) (10) (11) . For example, Cats B and L and their endogenous inhibitor, cystatin C, are highly expressed in the outer, invasive layer of trophoblast giant cells and the decidual capsule of normal mice embryo during the invasive period, as well as being secreted in trophoblast cell culture media, implying that the process is mediated by cysteine proteinases (12, 13) . On the other hand, several MMPs and TIMPs are also expressed at the maternal-embryonic boundary during mouse embryo implantation (14) and in trophoblast cells (15) . Since, in addition to the degradation of matrix components, CatB and CatL are capable of proteolytic activation of MMPs and u-PA (16) (17) (18) , the proposed interplay between these proteases in tumor cell invasion may also apply in the endothelial cell invasion needed for capillary sprouting from pre-existing vessels (7, 19) . For example, Cat B was suggested as an angiogenic activator in osteoarthritic cartilage because of its proteolytic degradation of tissue inhibitors of metalloproteinases (TIMPs) (20) . Recent publications have also shown intense staining for CatB in new capillaries in different tumors (21) (22) (23) (24) . MMP2 or gelatinase A (also called collagenase type IV) has been proposed as an effector protease in matrix remodeling by endothelial cells, and host-derived gelatinase A has been shown to be necessary for promoting tumor angiogenesis, although its cellular origin was not defined (25) . In contrast to other MMPs, MMP2 can bind to the integrin α v β 3 expressed on the plasma membrane of activated endothelial cells, and prevention of this binding suppressed angiogenesis (26) . MMP inhibitors also prevented capillary growth in in vitro models (27) .
The aims of this study were to investigate the potential role of cysteine proteinases CatB and CatL and compare it with that of MMP2 in the process of capillary sprouting, and subsequently to compare their mRNA expression in endothelial cells exposed to angiogenesis stimulating factors. Our results show that, in the aorta ring model, endothelial CatB and CatL do not contribute to capillary sprouting in collagen matrix and the collagen matrix itself promotes angiogenesis by stimulating endothelial cell expression of MMP2 but has no significant effect on CatB and CatL expression.
MATERIALS AND METHODS

Materials
A primary culture of human dermal microvascular endothelial cells (HMVEC-d), endothelial basal medium (EBM-2) and endothelial growth medium (EGM-2, composed of ascorbic acid, gentamycin, amphotericin B and human recombinant vascular endothelial growth factor VEGF, basic fibroblast growth factor bFGF, hydrocortisone, epidermal growth factor EGF and insulin-like growth factor R3-IGF-1, dissolved in EBM-2) were obtained from Clonetics (San Diego, California, USA). VEGF 165 was from SIGMA (Saint Louis, Missouri, USA) and bFGF from Oncogene (Boston, Massachusetts, USA). Cell culture flasks and multi-well plates were obtained from Costar (Cambridge, Massachusetts, USA), four-well dishes were from Nunc (Roskilde, Denmark), TRIZOL reagent from Invitrogen (Paisley, UK) and PBS from Euroclone (Wetherby, UK). Selective CatB inhibitors L-transepoxysuccinyl-Ile-Pro-OH propylamide (CA-074) and Ltrans-epoxysuccinyl-Ile-Pro-OMe propylamide (CA-074Me), the general cysteine proteinase inhibitor L-transepoxysuccinyl-Leu-3-methylbutylamide (E-64c), and Ltrans-epoxysuccinyl-Leu-3-methylbutylamide ethyl ester (E-64d) were obtained from Bachem (Bubendorf, Switzerland). The MMP inhibitor batimastat (BB-94) was a gift from British Biotech (Oxford, UK). Quantitative RT-PCR reagents, High-Capacity cDNA Archive kit, RNase inhibitor and 18S pre-developed TaqMan assay reagent were supplied by Applied Biosystems (Foster City, CA, USA). TaqMan Universal Master Mix was obtained from Roche (New Jersey, USA) and MTT (1-(4,5-dimethylthia-zol-2-yl)-2,5-diphenyl tetrazolium bromide) reagent from SIGMA (Steinheim, Germany). Polyclonal antibodies against F-VIII were obtained from DAKO (Copenhagen, Denmark).
Aorta ring assay
The aorta ring assay was performed as described previously (28, 29) . One to two-month-old Wistar male rats were sacrificed in CO 2 . The thoracic aorta was removed immediately under sterile conditions, cleaned of periadventitial fibroadipose tissue and sliced by surgical blade to give rings of 1 mm thickness. Rings were rinsed extensively in serum-free EBM-2 and cultured separately in 16 mm four-well dishes in 35 mL of gelling rat-tail tendon collagen. Collagen was purified from rat-tail tendons as reported previously (30) . The final concentration (1 mg/mL) was obtained by mixing eight volumes of collagen in 1/10 MEM (1.25 mg/mL), pH 4.0 with one volume of 10 X MEM (minimum essential medium, SIGMA, Saint Louis, Missouri, USA) and one volume of NaHCO 3 (23.4 mg/mL). Collagen was applied over each ring to form a disc-shaped three-dimensional matrix. The aorta rings were oriented parallel to the bottom of the culture dish. After 10 min of gelling at 37°C in a 5% CO 2 atmosphere, 0.5 mL of serum-free EBM-2 with VEGF 165 (10 ng/mL) was added to each culture. To investigate the impact of CatB, CatL and MMP in angiogenesis, samples were cultured in the same medium in the presence of two general inhibitors of cysteine proteinases (CPIs), E-64c (2, 10, 50 µM), which does not penetrate the cells, and E-64d (0.4, 2, 10 µM), a selective CatB inhibitor, CA-074 (2, 10, 50 µM), which inhibits extracellular CatB, and its derivative CA-074Me (0.4, 2, 10 µM), which can penetrate the plasma membrane and inhibit intracellular CatB. For MMP inhibition batimastat BB-94 was used at a final concentration of 0.2 µM. Cultures were kept in a humidified incubator at 37°C and 5% CO 2 . The medium was replaced every other day starting from day 3. The angiogenic response of cultures was measured by counting the number of sprouting capillaries over time according to published criteria (28) . Images were taken with a Nikon E995 digital camera (Nikon, Tokyo, Japan) mounted on a Reichard-Jung microscope (Buffalo, NY, USA).
Histological staining
Aorta ring cultures were rinsed in PBS, fixed in 4% formalin, and embedded in paraffin. Serial sections of 15 µm thickness were deparaffinized with two changes of xylene, rehydrated in graded ethanol solution and washed with distilled water for five minutes. The rehydrated tissue was pre-treated in EDTA buffer (pH 8.0) for 15-20 min and heated at 96°C in a microwave oven (Polar patent PP-780) to expose antigen epitopes. The specimens were cooled and incubated with primary antibod-ies against factor VIII. Indirect streptavidin-peroxidase reactions were performed using goat anti-mouse/antirabbit IgG biotinylated secondary antibodies, streptavidin-horseradish peroxidase and chromogen diaminobenzidine. The specimens were washed, counterstained with Mayer's hematoxylin and mounted. Images were obtained by a Nikon camera Coolpix 995 mounted on a Nikon Eclipse E 800 microscope (Nikon, Tokyo, Japan).
Cell cultures
HMVEC-d (human dermal microvascular endothelial cells) were grown in the endothelial growth medium (EGM-2 BulletKit) in plastic cell culture flasks. For analysis of mRNA expression 25,000 cells per well were seeded on twelve-well tissue culture plates. After 24 hours the wells were divided into four different groups for further treatment. Wells of each group were rinsed with PBS and treated with different medium for further growth: the first group with EGM-2 BulletKit, the second with EBM-2 medium, which contains 5% FBS (fetal bovine serum, EuroClone, Wetherby, UK), the third with EGM-2 Bul-letKit and VEGF 165 (30 ng/mL), and the fourth with EGM-2 BulletKit and bFGF (30 ng/mL). Medium was replaced every 24 hours. Cells were treated for 6, 12, 24, 36, 48 and 72 hours. Samples were treated in triplicate for each medium and time of treatment.
In another set of experiments the following media were used: for the first group, EGM-2 BulletKit, for the second, EBM-2 containing 5% FBS, for the third, EBM-2 containing 5% FBS and VEGF 165 (30 ng/mL), and for the fourth, EBM-2 containing 5% FBS and bFGF (30 ng/mL).
For seeding on collagen, 150 µL of gelling collagen (1 mg/mL in 1xMEM) was spread in wells of 24-well low attachment plates. Plates were left in an incubator for one hour to allow gelling of collagen. Cells were then seeded on the surface of the collagen. For seeding into the collagen matrix, cells were resuspended in gelling collagen solution (1 mg/mL in 1xMEM). 150µL of gelling collagen containing 25,000 cells was spread in wells of 24-well low attachment plates. After 30 min of gelling, treatment media were added over the culture. After treatment the cells were rinsed with PBS and lysed in 1 mL of Trizol Reagent per well and the lysate was stored in Eppendorf tubes at -80°C until the isolation of total RNA. Total RNA was isolated according to the Trizol Reagent protocol.
Quantitative RT-PCR primers and probes
Primers and probes were designed using Primer Express software (Applied Biosystems, Foster City, USA) and synthesized with FAM at the 5' end and TAMRA at the 3' end. We used the following primers and probes. MMP2: Forward primer, 5'-TTGATGGCATCGC TCA-GATC-3', Reverse primer, 5'-TTGTCACGTGGCGT-CACAGT-3', Probe: 5'-CTTCAAGGACCGGTTCATTTG-GCG-3, CatB: Forward primer, 5'-CTCTATGAATCC-CATGTAGGGTGC-3', Reverse primer, 5'-CCTGTTTG-TAGGTCGGGCTG-3', Probe, 5'-CTTCAAGGACCG-GTTCATTTGGCGG-3'. CatLa 1,2 : Forward primer, 5'-AGCGTCTACCCCGAACTCTG-3', Reverse primer, 5'-TTGTGCATCGCCTTCCAC -3', Probe, 5'-ACTCATC-CTTGCTGCCTTTTGCCTGG-3'.
For specific PCR amplification, the primers and the probe were designed at the 5' end of the sequence to avoid regions of higher homology. The 5' end of the transcript is processed in different splicing variants (31) . With our primers and probe selection we were able to amplify the most commonly expressed splicing variants CatLa, CatLa 1 and CatLa 2
Reverse transcription and quantitative RT-PCR
Total RNA was reverse transcribed to cDNA using a High-Capacity cDNA Archive Kit according to the manufacturer's protocol. One U/µL of RNase inhibitor was used in the reaction mixture for RNA protection. Reverse transcription was performed on a PTC-200 thermal cycler (MJ Research, Watertown, USA) with two-step incubation at 25˚C for 10 min and 37˚C for 120 min. Quantitative PCR reactions were carried out on an ABI PRISM 7900HT Sequence Detection System (Applied Biosystems, Foster City, USA). PCR reactions were performed under standard conditions (UNG incubation: 50°C, 2 min, hot start: 95°C, 10 min, 40 cycles of denaturation at 95°C, for 15 seconds and annealing-elongation at 60°C for 1 min). In each sample, gene cDNA was coamplified with 18S cDNA. The reaction mixture was prepared by TaqMan Universal Master Mix, 18S pre-developed TaqMan assay reagent and gene-specific primers and probe. Primers and probe were used at final concentrations of 100 nM and 50 nM, respectively. Gene expression data were analyzed as suggested in ABI PRISM ® 7700 SDS User Bulletin #2 for relative quantification using multiplex reactions with the comparative ∆∆C T method. For quantification of the data, gene cDNA levels were normalized to the sample 18S cDNA levels in the same reaction. Data are shown as relative changes in the expression of the analyzed gene before and after treatment.
Statistical analysis
Mean values of the parallels and standard errors of the mean (SEM) were calculated using the SPSS software (SPSS Inc., USA). Statistical significance of the differences between the samples was determined by the twotailed t test with assumed equal variance and p<0.05 was considered statistically significant.
RESULTS
New vessel formation in rat aortic explants
Rings of rat thoracic aorta were embedded in collagen gel and cultured in serum-free EBM-2 medium. After 24 hours, the first fibroblast-like cells started to migrate from the aorta into the gel. The first capillaries to sprout from the cut end of aortas were observed on day 3 and reached a peak number on day 6 ( Fig. 1 A, B) . Initially, linear sprouts were branching and anastomosing to form a complex network. Capillaries were distinguished from fibroblast-like cells by their specific morphology (Fig.  1C, D) . Their phenotype was confirmed by immunohistological staining for vascular marker F-VIII. Endothelial cells in capillaries stained in the typical granular pattern, while sparse fibroblast-like cells remained unstained. Aorta cultures responded positively to VEGF stimulation, resulting in increased numbers of capillaries. After day 6, capillaries started to reduce in number, associated with massive proteolytic degradation of collagen gel ( Fig. 2A ).
Fig. 1 -Aorta ring response to VEGF stimulation. Capillary outgrowth from aorta explants in (A) control; (B) in the presence of VEGF (30ng/ml) (bar, 1mm); (C) Immunolabelling with endothelial marker Factor VIII (arrow head), non-stained fibroblast-like cells (arrows, 400 x magnification, bar 50µm); (D) Typical granular staining of F-VIII (arrow head, detail from C).
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Effect of CPIs and BB-94 on capillary growth from rat aortic explants and on collagen matrix degradation
We used the synthetic inhibitors E-64c and E-64d to evaluate the role of cysteine cathepsins in proteolysis, and CA-074 and CA-074Me to evaluate the involvement of CatB in the degradation of collagen matrix associated with capillary growth in the aorta ring assay. E-64d and CA-074Me have been designed to enter the cells and inhibit lysosomal cathepsins, whereas E-64c and CA-074 act extracellularly. We determined the highest non-toxic concentrations of inhibitors on cultured, spontaneously immortalized rat aortic endothelial cells by 1-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay (MTT, data not shown). These were below 50 µM for CA-074, 10 µM for CA-074Me, 50 µM for E-64c and 10 µM for E-64d. For MMP inhibition we used BB-94 (bati-mastat), which was not toxic to cells below a concentration of 1 µM. In aorta ring cultures, no reduction in capillary number was observed by any of the cysteine proteinase inhibitors. Degradation of collagen in regressing cultures was similar to that in controls in the case of selective CatB inhibitors, whereas in the presence of E-64c the pattern of collagen degradation was altered compared to no inhibition in the control (A), which indicates partial inhibition of proteolysis by cysteine proteinases.
In the presence of 0.2 µM MMP inhibitor BB-94, capillary growth was significantly reduced (Figs. 2 and  3) , as determined by the t test (p<0.001). BB-94 also prevented collagen gel degradation in regressing cultures (Fig. 2B) . These results suggest that in our model capillary growth depended on endogenous MMP degradation of collagen, whereas the activity of cysteine proteinases was not required. 
Expression of CatB, CatL and MMP2 mRNA in HMVEC-d under different growth conditions
We performed RT-PCR quantitative analysis of CatB, CatL and MMP2 gene expression in primary cultures of human dermal microvascular endothelial cells (HMVECd), under conditions that mimic some of those in the aorta ring model. Cells in serum-free medium underwent apoptosis, so 5% of FBS was included in all treatment media. After stimulation of cells with the pro-angiogenic growth factors VEGF and bFGF, we isolated total RNA and determined the normalized expression of the proteinase genes. HMVEC-d was seeded either on the surface of the collagen gel or resuspended in the gelling collagen, and the expression of mRNA for CatB, CatL and MMP2 was measured. There was a gradual decrease in CatB expression (p=0.05; Fig. 4a ) to about half the initial value, while CatL expression gradually increased up to twofold (p=0.05; Fig. 4b ). Under the same treatment conditions, the MMP2 mRNA-level increased tenfold after 48 hours in all media used, indicating that the presence of FBS and growth factors did not affect its expression (Fig. 4c) .
When HMVEC-d cells were grown on plastic, no significant changes in the expression of CatB and CatL were observed in any of the media used (not shown). In contrast to the growth in collagen, MMP2 expression did not change over 72 hours when grown in growth medium (EGM-2) with all necessary supplements, demonstrating the strong dependence of MMP2 expression on the collagen matrix. However, the expression of MMP2 also increased, even when grown on plastic, when all growth factors were removed, e.g. in simple basal EBM-2 medium supplemented with FBS ( Fig. 5 ). This result clearly shows that growth factors can inhibit MMP2 expression ( Fig. 6 ). MMP2 expression was found to be inversely dependent on the presence of each growth factor. Thus, when cells grew on plastic, VEGF and bFGF inhibited the production of MMP2. When cells grew on the collagen matrix, VEGF and bFGF had no effect on the proteinase expression. Hence, under these conditions collagen alone induced MMP2 expression in HMVEC-d culture.
DISCUSSION
Although angiogenesis is a normal physiological process, it is also essential for malignant tumor growth, as has been shown in clinical and experimental studies of various cancers (1) . Formation of new blood vessels may occur through a number of different processes, although sprouting from existing vessels has been investigated most (2) . This process involves invasion of endothelial cells, which may use the same proteolytic cascades to proliferate, modify the extracellular matrix and migrate, just like invading tumor cells do (32) . Invasion of tumors by endothelial cells is mediated by two major groups of enzymes, MMPs and the Plg-uPA system (25, 33) , but it is less certain whether there is a role for cathepsins in angiogenesis. In a previous study we observed stronger immunostaining of CatB in new capillaries in human glioblastomas than in astrocytomas, and the presence of CatB in the endothelium was a highly significant marker of bad prognosis for patient survival (21) . High CatB expression in glioblastoma was reported by Mikkelsen et al (34) and has also been found in prostate and breast carcinoma (23, 24) . However, it is not known whether CatB was produced by endothelial cells or whether it was endocytosed from the microenvironment, as tumor cells and stromal cells may produce and secrete the enzyme in larger amounts (7, 35) .
In the rat aorta ring model, capillary growth was not inhibited by general inhibitors of cysteine cathepsins or by selective CatB inhibitors. The results obtained with specifically designed inhibitors, which can either act on the cell surface or enter the cell, lead to the conclusion that cathepsin activity is not required for capillary outgrowth in this model nor for direct extracellular or subsequent intracellular degradation of the matrix. However, slight inhibition of collagen degradation by E-64c was observed in the regression phase, indicating some extracellular activity of cysteine proteases in aorta culture. Shi and coworkers (36) reported that inhibition of CatS activity reduced microtubule formation of human saphenous vein endothelial cells by impairing cell invasion, and that endothelial cells from CatS-deficient mice displayed defective microvessel development during wound repair. Our data are not in line with their finding that the cysteine proteinase inhibitor E-64d inhibited bovine aortic endothelial cell invasion through collagen and Matrigel as well as bovine endothelial cell tube formation in 3D collagen gel, although the more complex aorta ring model is not directly comparable to their experimental models. However, a role for CatB and CatL in vivo cannot be excluded, as there are other pathways of angiogenesis such as intussusceptive capillary growth (37) , a process which may well use intracellular lysosomal cysteine proteinases in capillary formation and which has not yet been studied. Alternatively, CatB and CatL may also par- (17), as does CatL (18), whereas CatL may also generate the angiogenic inhibitor endostatin from collagen XVIII (38) , thereby reducing angiogenesis in vivo. We found strong inhibition of capillary growth in the aorta ring model by the general MMP inhibitor batimastat. It also prevented proteolytic degradation of collagen matrix in the regression phase of aorta ring culture, suggesting that most of the collagenolytic activity around the aorta depends on MMPs. The gelatinases MMP2 and MMP9 and membrane type MT1-MMP are the most relevant proteinases in angiogenesis, although the cellular origin of these enzymes in vivo may vary. Sounni et al (39) reported that MT1-MMP expression in tumor cells is crucial for the angiogenic switch, whereas MMP2 expression is not, and the enzyme is most probably produced by endothelial cells.
It has already been shown that the angiogenic response in aorta ring culture is modulated by matrix components and by endogenous VEGF and bFGF (40) (41) (42) , so we used these growth factors to stimulate growth of HMVEC-d and investigate if they induce the expression of cathepsins and MMP2. Our data clearly showed that the levels of CatB and CatL were not markedly altered during proliferation of cultured endothelial cells, when stimulated by growth factors VEGF and bFGF and/or by the collagen matrix, although there was a trend to increased expression of CatL during cell proliferation on the collagen substrate.
On the other hand, a 10-fold increase in MMP2 mRNA expression in cultures of HMVEC-d cells was observed in the presence of collagen gel, but independently of growth factor stimulation. This suggests that collagen is the major regulator of MMP2, at least when compared with VEGF and bFGF. This is in agreement with the results of Haas et al (43) , who also reported the induction of MMP2 mRNA by collagen. Surprisingly, when grown on plastic, MMP2 expression was not induced in rich growth medium but only in simple, basal medium supplemented with FBS ( Fig. 5 ). Moreover, our data clearly show that the addition of growth factors gradually suppressed MMP2 expression in the absence of collagen substrate. This finding is at variance with the data in the literature, which are themselves contradictory. Lamorreaux et al (44) reported an increase in MMP2 protein on VEGF stimulation, whereas Unemori et al (45) found no change in MMP2 mRNA expression. The different effect of growth factors on MMP2 expression observed on collagen gel and plastics appears to be a consequence of the cross-talk with integrin signaling after binding to the different surfaces. It has previously been shown in tro-phoblasts that MMP2 expression may depend on cell adhesion by integrin α v β 3 (46) . Integrin α v β 3 was expressed also in our cells (data not shown). Capillary destruction in regressing aorta ring cultures suggests that excessive MMP proteolytic activity may be counterproductive in the progression of angiogenesis in vivo. Negative regulation of MMP2 by VEGF and bFGF may therefore downregulate such excessive proteolysis. Our results suggest that endothelial cell-associated cathepsins B and L are not involved in invasive growth of capillaries from existing blood vessels and that the presence of collagen is necessary for MMP2 expression in endothelial cells. Further research using a more complex model of angiogenesis and HMVEC-d invasion will be needed to explain the data from clinical studies, where high CatB protein was demonstrated in new capillaries.
